Interestingly, S protein may compete with physiological ligands for binding to NRP1 and cause some of the dysfunctions reported in COVID-19 patients such as loss of olfaction, analgesic effects, immune interference and modulations of signaling pathways [80]. This evidence concerns the gene NRP1 and COVID-19.